PBX1 and neoplasm: In summary, the present study demonstrates TRIM26 is a first reported ubiquitin ligase of PBX1 and elucidates the detailed mechanism under TRIM26 promotes NSCLC cell proliferation and tumor growth by targeting PBX1.